Kidney Disease in Systemic Amyloidosis: A Review of Amyloid, Amyloid Serum A Protein, Leukocyte Chemotactic Factor 2, and Transthyretin Amyloid.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 101766381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2641-7650 (Electronic) Linking ISSN: 26417650 NLM ISO Abbreviation: Kidney360 Subsets: MEDLINE
    • Publication Information:
      Publication: 2023- : [Hagerstown, MD] : Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology
      Original Publication: [Washington, DC] : American Society of Nephrology, [2020]-
    • Subject Terms:
      Serum Amyloid A Protein*/metabolism ; Amyloidosis*/blood ; Amyloidosis*/metabolism ; Prealbumin*/metabolism; Humans ; Kidney Diseases/blood ; Kidney Diseases/metabolism ; Intercellular Signaling Peptides and Proteins
    • Abstract:
      Systemic amyloidoses are a group of disorders that can be hereditary or acquired and have various renal manifestations and outcomes. Light chain amyloid has been considered the most common renal amyloid and, thus, has been the focus of substantial research and therapeutic interest but with improvement in diagnostic techniques. However, there has been growing interest in rarer forms of renal amyloid, including amyloid serum A protein, leukocyte chemotactic factor 2 amyloid, and transthyretin amyloid. In this review, we provide an update on diagnostics, renal outcomes, and therapeutic landscape in these specific types of amyloid.
      (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.)
    • References:
      Blood. 2021 Dec 23;138(25):2632-2641. (PMID: 34521113)
      Drugs. 2024 Apr;84(4):473-478. (PMID: 38413492)
      Orphanet J Rare Dis. 2022 Jul 9;17(1):259. (PMID: 35810311)
      N Engl J Med. 1986 Apr 17;314(16):1001-5. (PMID: 3515182)
      Blood. 2009 Dec 3;114(24):4957-9. (PMID: 19797517)
      Kidney Int. 2023 Mar;103(3):473-484. (PMID: 36502873)
      JACC CardioOncol. 2024 Apr 16;6(2):300-306. (PMID: 38774010)
      Mod Pathol. 2016 Apr;29(4):416-20. (PMID: 26867784)
      Glob Cardiol Sci Pract. 2023 Jan 30;2023(1):e202304. (PMID: 37928601)
      Am J Kidney Dis. 2023 May;81(5):606-610. (PMID: 36228827)
      J Clin Oncol. 2012 Mar 20;30(9):989-95. (PMID: 22331953)
      Clin Chem. 2009 Aug;55(8):1517-22. (PMID: 19520758)
      ESC Heart Fail. 2023 Feb;10(1):397-404. (PMID: 36259276)
      Blood. 2015 Apr 2;125(14):2239-44. (PMID: 25636337)
      Clin J Am Soc Nephrol. 2013 Sep;8(9):1515-23. (PMID: 23704299)
      Am J Nephrol. 2022;53(4):297-306. (PMID: 35325889)
      Clin Kidney J. 2022 Jun 15;16(2):397-398. (PMID: 36755844)
      Arthritis Rheum. 2006 Jan;54(1):105-14. (PMID: 16385502)
      Amyloid. 2013 Sep;20(3):142-50. (PMID: 23713495)
      Cardiovasc Pathol. 2021 Nov-Dec;55:107375. (PMID: 34371188)
      Kidney Int. 2008 Jul;74(2):218-22. (PMID: 18449172)
      Blood. 2014 Oct 9;124(15):2325-32. (PMID: 25115890)
      Heart Fail Rev. 2024 Mar;29(2):511-521. (PMID: 38233673)
      Pharmaceuticals (Basel). 2023 Apr 21;16(4):. (PMID: 37111386)
      Eur J Heart Fail. 2024 Feb;26(2):397-410. (PMID: 38321786)
      Eur Heart J. 2013 Feb;34(7):483-5. (PMID: 22927558)
      Amyloid. 2022 Mar;29(1):8-13. (PMID: 34766859)
      Clin J Am Soc Nephrol. 2012 Aug;7(8):1337-46. (PMID: 22537653)
      Proteins. 2022 Dec;90(12):2080-2090. (PMID: 35841533)
      N Engl J Med. 2007 Jun 7;356(23):2349-60. (PMID: 17554116)
      J Peripher Nerv Syst. 2022 Dec;27(4):228-237. (PMID: 36345805)
      Nephrol Dial Transplant. 2019 Sep 1;34(9):1460-1466. (PMID: 30299492)
      Amyloid. 2011 Jun;18 Suppl 1:80-2. (PMID: 21838441)
      Ann Med. 2017 Nov;49(7):545-551. (PMID: 28271734)
      Kidney Int. 2014 Aug;86(2):370-7. (PMID: 24451324)
      N Engl J Med. 2021 Jul 1;385(1):46-58. (PMID: 34192431)
      Amyloid. 2017 Mar;24(sup1):81-82. (PMID: 28434370)
      N Engl J Med. 2007 Jun 7;356(23):2361-71. (PMID: 17554117)
      Sci Transl Med. 2018 Jan 3;10(422):. (PMID: 29298867)
      N Engl J Med. 1997 Apr 24;336(17):1202-7. (PMID: 9110907)
      J Biol Chem. 1999 Feb 12;274(7):4300-8. (PMID: 9933631)
      Front Cardiovasc Med. 2022 Jun 27;9:900313. (PMID: 35833187)
      PLoS One. 2017 Sep 19;12(9):e0185078. (PMID: 28926601)
      Clin Kidney J. 2022 May 05;15(9):1747-1754. (PMID: 36003663)
      Amyloid. 2022 Dec;29(4):213-219. (PMID: 36420821)
      Nephrol Dial Transplant. 2008 Mar;23(3):941-51. (PMID: 17951308)
      Arthritis Rheum. 2006 Jun;54(6):2015-21. (PMID: 16732553)
      Blood. 2012 Oct 18;120(16):3206-13. (PMID: 22948045)
      N Engl J Med. 2024 Jan 11;390(2):132-142. (PMID: 38197816)
      Arch Intern Med. 1992 Nov;152(11):2245-50. (PMID: 1444684)
    • Accession Number:
      0 (Serum Amyloid A Protein)
      0 (LECT2 protein, human)
      0 (Prealbumin)
      0 (Intercellular Signaling Peptides and Proteins)
    • Publication Date:
      Date Created: 20241002 Date Completed: 20241226 Latest Revision: 20250104
    • Publication Date:
      20250104
    • Accession Number:
      PMC11687988
    • Accession Number:
      10.34067/KID.0000000600
    • Accession Number:
      39356570